The findings highlight the importance of conversations between doctors and patients about drug costs.
Rheumatoid arthritis is known to increase the risk of heart disease, but taking biologic medications that help lower inflammation and disease activity can help you stay healthy.
Medication changes are par for the course when managing a chronic condition like rheumatoid arthritis. Here’s what to expect if you’re thinking about a change in your RA treatment plan.
Osteoarthritis patients taking canakinumab (Ilaris) in the study were less likely to need joint replacement surgery, which suggests the medication may be useful in treating osteoarthritis.
While many studies have shown these medications help treat AS symptoms, more research has been needed about their impact on long-term disease progression.
Although steroids are known to have serious side effects when used for an extended period, limited attention has been paid to the risks of using these medications for only a few days or weeks.
Tremfya, already approved for psoriasis, inhibits an immune system protein called IL-23 that can lead to inflammation.
Cosentyx is the second interleukin-17 drug approved for non-radiographic axial spondyloarthritis, which is adding to treatment options for patients with this type of inflammatory arthritis.
Formerly prescription-only, the NSAID Voltaren gel will now be sold over the counter. Here’s what it means if you have arthritis and use this cream for pain relief.
A small animal study published earlier this year suggests that timing of non-steroidal anti-inflammatory medication can affect their effectiveness.
A new study found that many patients who tapered their meds wound up flaring.
Approved in 2019 for moderate to severe rheumatoid arthritis, the drug may offer an oral alternative to infused or injected biologics.
In a ‘head-to-head’ clinical trial, Cosentyx, an IL-17 inhibitor, cleared skin better than Humira and it did just as well treating joint problems.
The difference may be patients’ prolonged exposure to anti-malarial drugs, new research suggests.
Prescribing higher doses of HCQ and adjusting the amount to reach a specific blood level target could help lupus patients avoid blood clots and related complications.
In uncontrolled gout, the infused treatment pegloticase is more tolerable and effective if methotrexate is given before and during treatment, new research shows.
Taltz, approved last year for ankylosing spondylitis, inhibits an immune system protein called IL-17 that can lead to inflammation.
Sometimes hydroxychloroquine is used off-label to treat erosive osteoarthritis, but more research suggests it is not helpful.
For many patients, side effects worsened right after the MTX dose.
The American College of Rheumatology’s updated gout guidelines emphasize treating as aggressively as necessary to keep urate levels low.
While many factors may explain why DMARDs don't work well in some people, a new study finds that a co-existing diagnosis of fibromyalgia might have something to do with it.
Some studies have suggested that more patients would benefit from starting with a combination of methotrexate and a TNF inhibitor from the time of an RA diagnosis, but new research is casting doubt on that idea.
Initially used to treat seizures, anticonvulsant medications have become more widely used to treat certain types of chronic pain, such as fibromyalgia.
The disease-modifying drug could help improve the effectiveness of biologic medications in axSpA.
According to a study of insurance claims data, about 20 percent of anti-TNF drug prescriptions filled were for brand-name infliximab (Remicade) while less than 1 percent were for an infliximab biosimilar.
RA patients were apt to receive a biologic drug sooner if they lived in an urban area closer to a prescriber.
Only about one-third of RA patients in high disease activity were offered a treatment change at their rheumatologist visit, according to a recent study in the ArthritisPower research registry.
Find out if you should give a TENS device a try to relieve your pain.
The new OA guidelines are designed more like a menu from which patients and providers can choose one or more approved items.
In looking specifically at cancer survivors with an autoimmune condition, those on anti-TNF drugs were not more likely to experience a cancer recurrence or develop a new type of cancer.
‘Naproxen caused fewer side effects supporting naproxen as first-line treatment for gout flares in primary care in the absence of contraindications.’
TENS, which stands for transcutaneous electrical nerve stimulator, involves sending mild electrical impulses to specific areas of your body.
Learn what to expect and how to prepare from the doctors who perform this operation every day and the patients who have been through knee surgery successfully.
Feeling queasy is a common side effect of many different arthritis drugs. Here’s how to handle this medication side effect.
These findings confirm that the usual treatment strategy in RA — early treatment, tight control, and treat to target — should be applied similarly to both seropositive and seronegative diseases.
Already approved for rheumatoid arthritis, upadacitinib may help other inflammatory conditions as well.
There was an increased risk of many different kinds of side effects, but most were mild.
Anifrolumab will seek FDA approval.
This may be a good option for patients who shouldn’t use NSAIDs or colchicine to treat gout flares.
"Giant cell arteritis requires ongoing management, but it does not necessarily require continuous treatment.”
Vagus nerve stimulation is being studied for its potential to help RA patients who don't respond to medication such as biologics. Here’s what you need to know.
The anti-malarial drug lowers cholesterol and blood sugar and makes blood less sticky, which is good for reducing blood clots and heart attack risk.
Screening is important because silent hepatitis B and C infections can spring to life when you start biologics or new synthetic DMARDs.
New data compares what happens when the dosage of DMARDs such as methotrexate is tapered or kept steady.
Already approved for psoriasis, the IL-23 inhibitor is looking good for patients with psoriatic arthritis.
Surprisingly, stronger opioids were the worst at relieving pain in a new multi-study analysis.
However, there was no immediate reduction in pain or improvement in hand function, a new study showed.
But the majority of MTX users felt that the medication protects them from getting worse, according to a new study.
The researchers found that people whose uric acid levels were higher than recommended had ‘over twofold higher mortality risk compared with similar patients with gout who met target [uric acid] levels.’
‘We now have a good treatment option and there are more to come. The future of nr-axSpA treatment looks bright.’
Do pharmacy inserts, drug ads, and internet chatter have you scratching your head, feeling overwhelmed, or flat-out panicking? Help is here.
These are questions every RA patient has considered at some point. Here are the answers you need to make better treatment decisions.
Make sure to go through these questions with your rheumatologist or other health care provider any time you start a new medication for rheumatoid arthritis.
This is an important finding for people to know, considering that NSAIDs are a first-line treatment for AS.
Many treatment options are available to address fibromyalgia’s various symptoms, so treatment for fibromyalgia should be multifactorial, individualized, and based on what specific issues and symptoms are affecting you most.
Here’s what to expect at each point in the disease, and how to keep gout from getting worse in the first place.
Drugs that block the immune system protein IL-17 may work better for clearing skin plaques than those that block TNF.
Steroid injections are given to relieve joint pain, but new research shows they were also associated with OA progression.
In our ‘Ask a Pharmacist’ column in collaboration with Walgreens and AllianceRx Walgreens Prime, we get the facts about how to know the best time to take your medication. The short answer: It depends.
Taking medication that directly targets the underlying inflammation seems to combat any increased risk for Alzheimer’s.
More medication options and updated research about medication effectiveness has led to an update in AS treatment guidelines from the American College of Rheumatology.
Taltz inhibits an immune system protein called IL-17 that can lead to inflammation.
It’s important to make sure gout treatment actually reduces deposits of uric acid crystals in the joints, aside from lowering blood levels.
Why you need to be monitored while you take MTX, what your doctor is looking for, and how you can help avoid medication-induced toxicity.
A study found that RA patients would fare equally well in terms of infection risk with either drug regimen.
The new JAK inhibitor is approved for adults with moderate to severe RA who can't tolerate methotrexate or don't respond sufficiently to it.
If you have arthritis, you’ve probably used or contemplated using corticosteroids. Which means you’ve likely also heard some of these common misconceptions.
Medication changes are common when you’re managing a chronic disease like arthritis. Here’s how to navigate them like a pro.
A certain subset of people was more likely to achieve and stay in remission after starting the anti TNF biologic adalimumab.
If you have trigger finger from Dupuytren’s, here’s what you should know about your treatment options to feel better and improve your quality of life.
It may be the case that psoriatic arthritis isn’t treated as aggressively as other inflammatory arthritis, like rheumatoid arthritis.
If you have inflammatory arthritis, you’ve probably heard of methotrexate. Which means you’ve likely also heard some of these common misconceptions.
The drug, approved for rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, has been linked to a higher risk of pulmonary embolism.
Here’s what could change next time you go to fill your prescription.
Non-steroidal anti-inflammatory drugs can have serious side effects. This new tool can help patients and doctors better assess risk.
Psoriatic arthritis is linked with an increased fracture risk, but taking biologic medication can help.
A new study suggests that these drugs might raise the risk of some of the same conditions that they're designed to treat.
This research could be used to help predict which patients will do well on methotrexate and which may not respond as well.
Other safer and more effective treatments are available to treat the pain from gout attacks.
On the other hand, RA patients are less likely than those with osteoarthritis to develop a dangerous blood clot.
Almost half of patients who start a TNF inhibitor biologic are not on the same treatment a few years later.
Learn what to expect and how best to prepare from the doctors who perform this operation every day, and the patients who have been through hip surgery successfully.
This painful eye inflammation can cause serious problems, such as vision loss. Here’s what to know about treating it.
When you begin an arthritis treatment, you may be concerned about hair loss as a side effect. Here’s how to handle it.
There’s no need to live with pain, fatigue, or other arthritis symptoms. These are clues it might be time to change your arthritis medication plan.
Many patients hope to be able to stop medication once they enter remission. Ongoing research can provide some clues as to who can do so successfully.
A new study found that AS patients on anti-TNF drugs had fewer doctor and ER visits and didn’t skip work as often.
No more infusion confusion.
Learn more about what can happen to your chances of being in remission when you stop taking a biologic drug.
From tests to detect silent hepatitis to checking cholesterol and blood sugar, these are critical to make sure you stay healthy while using biologic drugs.
It can be a big adjustment to give yourself injections. These tips can make the process less scary.
There are many drug options for managing active PsA. Here’s what happened when a study compared them with each other.
For patients, remission often means more function and less pain. Here’s what else you need to know.
Learn more about Evenity, a new medication that may help prevent fractures in high-risk patients.
You’ve heard your doctor talk about these treatment goals, but here’s more on what it takes to get there.
A new study found that chronic opioid use among people with RA doubled between 2002 and 2015.
Almost half of patients had major improvements in their disease activity compared to only 7 percent of those given a placebo.
Learn more about the role of COX-2 inhibitors in heart valve calcification — and what it could mean for you.
The FDA is expected to rule on upadacitinib by the end of this summer.
When other treatments aren’t working, see if these shots to relieve the painful symptoms of knee osteoarthritis may be right for you.